Cargando…
Advances and Challenges of Liposome Assisted Drug Delivery
The application of liposomes to assist drug delivery has already had a major impact on many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664963/ https://www.ncbi.nlm.nih.gov/pubmed/26648870 http://dx.doi.org/10.3389/fphar.2015.00286 |
_version_ | 1782403522239660032 |
---|---|
author | Sercombe, Lisa Veerati, Tejaswi Moheimani, Fatemeh Wu, Sherry Y. Sood, Anil K. Hua, Susan |
author_facet | Sercombe, Lisa Veerati, Tejaswi Moheimani, Fatemeh Wu, Sherry Y. Sood, Anil K. Hua, Susan |
author_sort | Sercombe, Lisa |
collection | PubMed |
description | The application of liposomes to assist drug delivery has already had a major impact on many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in vivo. This enables effective delivery of encapsulated compounds to target sites while minimizing systemic toxicity. Liposomes present as an attractive delivery system due to their flexible physicochemical and biophysical properties, which allow easy manipulation to address different delivery considerations. Despite considerable research in the last 50 years and the plethora of positive results in preclinical studies, the clinical translation of liposome assisted drug delivery platforms has progressed incrementally. In this review, we will discuss the advances in liposome assisted drug delivery, biological challenges that still remain, and current clinical and experimental use of liposomes for biomedical applications. The translational obstacles of liposomal technology will also be presented. |
format | Online Article Text |
id | pubmed-4664963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-46649632015-12-08 Advances and Challenges of Liposome Assisted Drug Delivery Sercombe, Lisa Veerati, Tejaswi Moheimani, Fatemeh Wu, Sherry Y. Sood, Anil K. Hua, Susan Front Pharmacol Pharmacology The application of liposomes to assist drug delivery has already had a major impact on many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in vivo. This enables effective delivery of encapsulated compounds to target sites while minimizing systemic toxicity. Liposomes present as an attractive delivery system due to their flexible physicochemical and biophysical properties, which allow easy manipulation to address different delivery considerations. Despite considerable research in the last 50 years and the plethora of positive results in preclinical studies, the clinical translation of liposome assisted drug delivery platforms has progressed incrementally. In this review, we will discuss the advances in liposome assisted drug delivery, biological challenges that still remain, and current clinical and experimental use of liposomes for biomedical applications. The translational obstacles of liposomal technology will also be presented. Frontiers Media S.A. 2015-12-01 /pmc/articles/PMC4664963/ /pubmed/26648870 http://dx.doi.org/10.3389/fphar.2015.00286 Text en Copyright © 2015 Sercombe, Veerati, Moheimani, Wu, Sood and Hua. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Sercombe, Lisa Veerati, Tejaswi Moheimani, Fatemeh Wu, Sherry Y. Sood, Anil K. Hua, Susan Advances and Challenges of Liposome Assisted Drug Delivery |
title | Advances and Challenges of Liposome Assisted Drug Delivery |
title_full | Advances and Challenges of Liposome Assisted Drug Delivery |
title_fullStr | Advances and Challenges of Liposome Assisted Drug Delivery |
title_full_unstemmed | Advances and Challenges of Liposome Assisted Drug Delivery |
title_short | Advances and Challenges of Liposome Assisted Drug Delivery |
title_sort | advances and challenges of liposome assisted drug delivery |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664963/ https://www.ncbi.nlm.nih.gov/pubmed/26648870 http://dx.doi.org/10.3389/fphar.2015.00286 |
work_keys_str_mv | AT sercombelisa advancesandchallengesofliposomeassisteddrugdelivery AT veeratitejaswi advancesandchallengesofliposomeassisteddrugdelivery AT moheimanifatemeh advancesandchallengesofliposomeassisteddrugdelivery AT wusherryy advancesandchallengesofliposomeassisteddrugdelivery AT soodanilk advancesandchallengesofliposomeassisteddrugdelivery AT huasusan advancesandchallengesofliposomeassisteddrugdelivery |